Showing 1,401 - 1,420 results of 229,510 for search '(( 5 ((teer decrease) OR (nn decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 1.48s Refine Results
  1. 1401
  2. 1402
  3. 1403
  4. 1404
  5. 1405
  6. 1406
  7. 1407
  8. 1408
  9. 1409
  10. 1410
  11. 1411
  12. 1412

    Data_Sheet_1_Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons.docx by Katalin A. Wilkinson (10193231)

    Published 2021
    “…There was a significant decrease in IL-1alpha and IL-1beta (Ag-Nil) concentrations as well as MCP-1 (Nil), supporting decreased immune activation and inflammation. …”
  13. 1413

    <i>Myotis rufoniger</i> genome sequence and analyses: <i>M</i>. <i>rufoniger’s</i> genomic feature and the decreasing effective population size of <i>Myotis</i> bats by Youngjune Bhak (3511349)

    Published 2017
    “…<div><p><i>Myotis rufoniger</i> is a vesper bat in the genus <i>Myotis</i>. Here we report the whole genome sequence and analyses of the <i>M</i>. …”
  14. 1414
  15. 1415
  16. 1416
  17. 1417
  18. 1418

    Table_1_Linoleic Acid Inhibits the Release of Leishmania donovani Derived Microvesicles and Decreases Its Survival in Macrophages.DOCX by Sheetal Saini (6560501)

    Published 2020
    “…Moreover, these microvesicles were suppressive concerning their bias toward the Th-2 type of immune responses (IL-10, Arginase) in mϕ. We suggest that LA plays a protective role in the immune response against L. donovani infection by inhibiting the release to Leishmania derived microvesicles and thus promoting Th-1 type immune response in mϕ.…”
  19. 1419
  20. 1420

    Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

    Published 2018
    “…<b><i>Methods:</i></b> The levels of 17 potential biomarkers with an association with cardiovascular risk were quantitated in plasma from 37 age- and gender-matched psoriasis patients and controls at baseline and in 21 psoriasis patients after 12 weeks of NB-UVB treatment to identify a systemic treatment response. <b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”